Consensus estimates for Evolv Technologies anticipate Q3 2026 revenue of $45.61 million and an EPS loss of $0.06, with the current share price of $4.54 trailing well behind the $9.81 average analyst target.
Investors are primarily focused on the growth trajectory of Annual Recurring Revenue (ARR) as the company transitions its go-to-market strategy toward a high-margin subscription model.
Recent performance was bolstered by a strong second quarter where Evolv added 70 new customers and raised its full-year 2026 revenue guidance to a range of $180-$185 million.
This report will be a key indicator of whether the company can maintain sales momentum while definitively moving past historical accounting restatements and internal investigations into its revenue recognition practices.